AnandaBasuMD
Endocrinology • Charlottesville, VADiabetes, Lipid Metabolism
Professor, Family Medicine, Mayo Medical School
Dr. Basu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
415 Ray C Hunt Dr
Fl 2
Charlottesville, VA 22903Phone+1 507-284-2511- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1994 - 1997
- Mayo Clinic College of MedicineClass of 1985
Certifications & Licensure
AL State Medical License 2023 - 2024
VA State Medical License 2017 - 2024
MN State Medical License 1997 - 2017- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes Start of enrollment: 2010 Feb 01
- USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes Start of enrollment: 2014 Jun 01
- At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- Hyperglycemia suppresses Lactate Clearance during Exercise in Type 1 Diabetes.Davide Romeres, Yogesh Yadav, F N U Ruchi, Rickey Carter, Claudio Cobelli, Rita Basu, Ananda Basu> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Jan 4
- 2 citationsA New Index of Insulin Sensitivity from Glucose Sensor and Insulin Pump Data: In Silico and In Vivo Validation in Youths with Type 1 Diabetes.Michele Schiavon, Alfonso Galderisi, Ananda Basu, Yogish C Kudva, Eda Cengiz, Chiara Dalla Man> ;Diabetes Technology & Therapeutics. 2023 Apr 1
- 1 citationsImpaired Diurnal Pattern of Meal Tolerance and Insulin Sensitivity in Type 2 Diabetes: Implications for Therapy.Yogesh Yadav, Davide Romeres, Claudio Cobelli, Chiara Dalla Man, Rickey Carter, Ananda Basu, Rita Basu> ;Diabetes. 2023 Feb 1
- Join now to see all
Journal Articles
- Paradigm Shifts in Nocturnal Glucose Control in Type 2 DiabetesRobert A Rizza, Ananda Basu, Rita Basu, The Journal of Clinical Endocrinology and Metabolism
Lectures
- Glucagon-Like Peptide 1 Modulates Reductions in Myocardial Blood Flow Reserve during Euglycemia and Hyperglycemia in Both Type 2 Diabetics and Non-DiabeticsRochester, MN - 6/15/2014
- Differential Regulation of Glucocorticoids and Insulin on Hepatic 11ß-Hydroxysteroid Dehydrogenase Type 1 Enzyme ActivityRochester, MN - 6/16/2014
Hospital Affiliations
University of Virginia Medical CenterCharlottesville, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
